Perrigo | PRGO - Ebit


Perrigo reported $93.4M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AbbVie USD 5.72B 69M Jun/2025
Abbott USD 2.54B 358M Dec/2025
Bayer EUR -399M 363M Sep/2025
Bristol-Myers Squibb USD 4.04B 1.78B Sep/2025
Corcept Therapeutics USD 10.22M 16.46M Sep/2025
Dr.Reddys Laboratories INR 13.94B 1.79B Dec/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
J&J USD 5.11B 2.3B Dec/2025
Merck USD 7.56B 1.19B Sep/2025
Nestle CHF 7.14B 689M Jun/2025
Pacira USD 13.15M 2.92M Sep/2025
Perrigo USD 93.4M 37.8M Sep/2025
Pfizer USD 4.57B 1.97B Sep/2025
Prestige Brands USD 79.67M 7.91M Sep/2025
Reckitt Benckiser GBP 1.79B 109M Dec/2024
Sanofi EUR 1.7B 2.17B Dec/2025
Supernus Pharmaceuticals USD -60.18M 72.33M Sep/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025
Xeris Pharmaceuticals USD 7.89M 2.46M Sep/2025
Zoetis USD 975M 40M Sep/2025